Featured
-
-
Article |
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
A candidate vaccine against SARS-CoV-2 that uses the yellow fever 17D live-virus vector is highly efficacious and displays a favourable safety profile in Syrian hamster, mouse and cynomolgus macaque models.
- Lorena Sanchez-Felipe
- , Thomas Vercruysse
- & Kai Dallmeier
-
Article
| Open AccessPrevention of tuberculosis in macaques after intravenous BCG immunization
The delivery route and dose of the BCG vaccine profoundly alters the protective outcome after Mycobacterium tuberculosis challenge in non-human primates.
- Patricia A. Darrah
- , Joseph J. Zeppa
- & Robert A. Seder
-
Letter |
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Immunization with Plasmodium falciparum sporozoites under chemoprophylaxis can protect against controlled human malaria infection with the same strain for at least 10 weeks, and protection correlates with polyfunctional T-cell memory.
- Benjamin Mordmüller
- , Güzin Surat
- & Peter G. Kremsner
-
Letter |
Immune clearance of highly pathogenic SIV infection
Cellular immune responses in rhesus macaques (Macaca mulatta) vaccinated with cytomegalovirus vectors expressing SIV proteins are able to stringently control highly pathogenic SIV infection, regardless of the route of challenge, after systemic spread; immunological and virological analyses of protected macaques followed for up to 3 years suggest that persistent immune surveillance by vaccine-elicited immune responses may have cleared the infection.
- Scott G. Hansen
- , Michael Piatak Jr
- & Louis J. Picker